Status:

COMPLETED

The Asthma Breathing Record Study

Lead Sponsor:

TidalSense

Collaborating Sponsors:

National Institute for Health Research, United Kingdom

Portsmouth Hospitals NHS Trust

Conditions:

Asthma

Eligibility:

All Genders

7+ years

Brief Summary

The study involves a new device, called 'N-Tidal C', which uses a method that has the potential to predict when asthma attacks are about to happen. The device works by accurately measuring an individu...

Detailed Description

People with more severe asthma suffer from frequent asthma attacks that require regular hospital admissions. These attacks are difficult to predict and can devastate the lives of patients. A new tool ...

Eligibility Criteria

Inclusion

  • Male or Female, aged ≥7 years.
  • Confirmed clinician diagnosis of asthma by examination of medical records, and based on accepted national and/or international criteria e.g. BTS/SIGN, or GINA.
  • Moderate or Severe asthma (defined as BTS stage 2-5)
  • Poorly controlled asthma (defined as an ACQ score of ≥1)
  • Exacerbation prone asthma (defined as at least 1 asthma exacerbation requiring oral corticosteroid treatment in the last 12 months).
  • Providing written informed consent, or parental/guardian consent and participant assent in the case of a child

Exclusion

  • Inability to understand or comply with study procedures and/or inability to give fully informed consent.
  • Known other lung, chest wall, neuromuscular, cardiac or other comorbidity or abnormality that would affect spirometry and/or other measures of lung function or TBCO2 measurements (including Breathing Pattern Disorder or Chronic Obstructive Pulmonary Disease).
  • Smokers (current or ex-smokers) with a \>10 pack year history.
  • In the opinion of the clinical investigator, the participant would have difficulty completing the study procedures consistently (for example, difficulty holding the device, or long periods of absence/travel) throughout the study period.

Key Trial Info

Start Date :

February 11 2020

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 31 2022

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT04504838

Start Date

February 11 2020

End Date

January 31 2022

Last Update

June 21 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Portsmouth Hospitals NHS Trust

Portsmouth, Hampshire, United Kingdom, PO6 3LY